Commercialisation opportunity
Researchers at Heriot-Watt University in Scotland have developed a range of probiotic microorganisms which protect fish against diseases such as furunculosis, enteric redmouth disease, streptococcosis, vibriosis and winter ulcer disease. In addition, these organisms act as a dietary supplement, enhance the growth and health of a wide range of fish species.
The probiotic would be suitable for use in fish farming and for ornamental fish. It will reduce the need to treat many diseases with antibiotics, having been shown to be active against a number of fish diseases for a wide range of fish species. To date there is no evidence of disease resistance.
The probiotic microoganisms can be added directly to the fishes’ regular food and acts as a nutritional supplement as well as controlling disease. Heriot-Watt is now looking for commercialisation partners.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
